Feasibility Testing the Engaged Approach to Lung Cancer Screening

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to assess feasibility and acceptability of the Engaged Approach to Lung Cancer Screening (EA-LCS) in diverse lung cancer screening (LCS) programs operating in a variety of geographic regions across Colorado and the US.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

‣ The trial incorporates a multilevel assessment and enrollment involves inclusion criteria at two levels: (1) LCS Program and (2) LCS Program Staff member.

‣ Program inclusion criteria (n = up to 8 sites):

⁃ Must conduct at least 50 low-dose computed tomography (LDCT) scans per year (baseline + follow-up)

⁃ Must be able to identify a primary contact person for LCS program operations (e.g., program coordinator, program navigator, program manager, etc.)

‣ Staff member inclusion criteria (n \

• 5 at each site/\

‣ 40 participants total):

⁃ Identified staff member of the LCS program site

⁃ \>18 years of age

⁃ Must be able to complete study surveys and interviews in English

⁃ Willing to provide informed consent

Locations
United States
Colorado
University of Colorado Hospital
RECRUITING
Denver
Contact Information
Primary
Kaitlyn Hoover
kaitlyn.hoover@cuanschutz.edu
7702387144
Time Frame
Start Date: 2024-03-11
Estimated Completion Date: 2026-12
Participants
Target number of participants: 40
Treatments
No_intervention: Control Group
Sites in the control condition will be asked to complete appropriate/relevant surveys and interviews with minor modifications as needed and use the same Electronic Health Record Data Abstraction process.
Experimental: Experimental Group
Sites randomized to use the EA-LCS materials will be given password-protected access to the program/toolkit web portal and encouraged to use any materials that fit the normal flow of clinic procedures. Materials available include both staff-facing and LCS candidate-facing materials.
Related Therapeutic Areas
Sponsors
Collaborators: Bristol-Myers Squibb
Leads: University of Colorado, Denver

This content was sourced from clinicaltrials.gov